Strong demand for anti-fibrinolytic therapies is expected to push the tranexamic acid market forward at a solid 5.22% CAGR. https://industrytoday.co.uk/health_and_safety/tranexamic-acid-market-is-expected-to-achieve-a-strong-522-cagr-reaching-usd-177-billion-by-2035